Cellulose-Encapsulated Magnetite Nanoparticles for Spiking of Tumor Cells Positive for the Membrane-Bound Hsp70
The development of highly sensitive approaches for detecting tumor cells in biological samples remains a critical challenge in laboratory and clinical oncology. In this study, we investigated the structural and magnetic properties of iron oxide nanoparticles incorporated into cellulose microspheres of two size ranges (~100 and ~700 μm) and evaluated their potential for targeted tumor cell isolation. In the smaller microspheres, magnetite-based magnetic nanoparticles (MNPs) were synthesized in situ via co-precipitation, whereas pre-synthesized MNPs were embedded into the larger microspheres. The geometrical characteristics of the resulting magnetic cellulose microspheres (MSCMNs) were assessed by confocal microscopy. Transmission electron microscopy and X-ray diffraction analyses revealed an average magnetic core size of approximately 17 nm. Magnetic properties of the MNPs within MSCMNs were characterized using a highly sensitive nonlinear magnetic response technique, and their dynamic parameters were derived using a formalism based on the stochastic Hilbert-Landau-Lifshitz equation. To evaluate their applicability in cancer diagnostics and treatment monitoring, the MSCMNs were functionalized with a TKD peptide that selectively binds membrane-associated Hsp70 (mHsp70), yielding TKD@MSCMNs. Magnetic separation enabled the isolation of tumor cells from biological fluids. The specificity of TKD-mediated binding was confirmed using Flamma648-labeled Hsp70 and compared with control alloferone-conjugated microspheres (All@MSCMNs). The ability of TKD@MSCMNs to selectively extract mHsp70-positive tumor cells was validated using C6 glioma cells and mHsp70-negative FetMSCs controls. Following co-incubation, the extraction efficiency for C6 cells was 28 ± 14%, significantly higher than that for FetMSC (7 ± 7%, <i>p</i> < 0.05). These findings highlight the potential of TKD-functionalized magnetic cellulose microspheres as a sensitive platform for tumor cell detection and isolation.
Authors
- Maxim Alekseevich Shevtsov (ORCID: https://orcid.org/0000-0002-8539-2239)
- E. Yu. Varfolomeeva (ORCID: https://orcid.org/0000-0003-3287-4709)
- Anastasiia Spitsyna
- O. G. Smirnov
- L. G. Yakovleva
- Yaroslav Marchenko (ORCID: https://orcid.org/0000-0002-7923-2175)
- V. V. Deriglazov (ORCID: https://orcid.org/0000-0002-1315-9008)
- B. D. Nikolaev
- V. A. Ryzhov (ORCID: https://orcid.org/0000-0002-0546-1805)
- Anastasia Dmitrieva
- Andrey L. Konevega
- Natalia Yudintceva
- Stephanie E. Combs
- Vasiliy Matveev
Institutions
- Peter the Great St. Petersburg Polytechnic University (RU)
- Kurchatov Institute (RU)
- TUM Klinikum (DE)
- Institute of Cytology (RU)
- Petersburg Nuclear Physics Institute (RU)
- Technical University of Munich (DE)
- Saint Petersburg State Pediatric Medical University (RU)
- St. Petersburg State Technological Institute (RU)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-12-23
- DOI
- https://doi.org/10.3390/ijms27010150
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Academy of Sciences
- Irkutsk Scientific Center, Siberian Branch, Russian Academy of Sciences